Optimizing Coronary Thrombolysis With IV Administration of Recombinant Tissue Plasminogen Activator-Reference-Cited by-同舟云学术

Optimizing Coronary Thrombolysis With IV Administration of Recombinant Tissue Plasminogen Activator

Published:1996-02 Issue:2 Volume:109 Page:510-515
ISSN:0012-3692
Container-title:Chest
language:en
Short-container-title:Chest

Author:

Prewitt Richard M.,Schick Usha,Ducas John

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference19 articles.

1. Gruppo Italiano Per Lo Studio Della Streptochinasi Nell'Infarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986; 1:397-401

2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988; 2:349-60

3. Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction;Wilcox;Lancet,1988

4. Randomized angiographic trial of recombinant tissue-type plasminogen activator (alteplase) in myocardial infarction;Carney;J Am Coll Cardiol,1992

5. The thrombolytic and hemorrhagic effects of tissue type plasminogen activator: influence of dosage regimens in rabbits;Agnelli;Thromb Res,1985

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 2022 Update of the Consensus on the Rational Use of Antithrombotics and Thrombolytics in Veterinary Critical Care (CURATIVE) Domain 6: Defining rational use of thrombolytics;Journal of Veterinary Emergency and Critical Care;2022-07

2. Intraoperative local fibrinolysis as emergency therapy after early coronary artery bypass thrombosis1;European Journal of Cardio-Thoracic Surgery;1999-03